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Abstract: This concept paper aimed to understand how stigma, a concept usually associated with
negative social relationships, in the context of a pandemic threat such as COVID-19 can, in some
situations, structure a charismatic social relationship in a perceived positive association between
stigma and a specific social characteristic. For this purpose, we used the example of the news selected
and highlighted by several Portuguese media about the actions and messages developed by President
Trump in the context of his infection with SARS-CoV-2 and the subsequent recovery process. These
news reports gave visibility to a narrative that can be considered as reinforcing the legitimization
of his condition as a charismatic leader in an electoral context marked by the pandemic threat. In
conclusion, stigma associated with a pandemic health threat and generally linked to a negative social
status can also reinforce admiration, trust, and belief in the charismatic leader by supporters and
followers, as demonstrated with the plight of President Trump. Stigma can be a factor in social uplift
in affirming an upward trajectory of social status and symbolic power for actors seen as ill, where
stigma-motivated discrimination is experienced positively, unlike in most cases.
Keywords: COVID-19 pandemic; SARS-CoV-2; stigma; stigmatization; charisma; charismatic domi-
nation; President Trump; legitimation; social elevation; media narrative; media
1. Introduction
This conceptual paper aimed to understand how stigma, a concept usually associated
with a negative social relationship, in the context of a pandemic threat such as COVID-19
can, in some situations, structure a charismatic social relationship in an association between
stigma and a socially positive dimension. For this purpose, the authors analyzed selected
news stories highlighted by several Portuguese media about the actions and messages
developed by President Trump in the context of his infection with SARS-CoV-2 and the
subsequent recovery process. These news items give visibility to a narrative that can
be considered as reinforcing the legitimization of his condition as supreme leader in an
electoral context marked by the pandemic threat [1].
The perception of this condition of a supreme chief is based on a gift, i.e., on the
extraordinary ability that chiefs possess. These exceptional gifts gain visibility and meaning
in the proclamation and realization of a political, warlike, religious, or philanthropic
objective, among others [2]. Those who acknowledge this gift also acknowledge the duty
to follow the charismatic leader, whom they obey exclusively because of their exceptional
qualities and not according to their statutory position or traditional dignity [3]. The
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influence of charisma is born and persists if the goal is achieved, i.e., if it offers effective
and useful evidence capable of strengthening the faith of the followers [2].
Charisma cannot be confused with prestige, consideration, popularity, or personal
talent. Charisma establishes a social relationship that fundamentally changes the struc-
ture of behavior [4]. Charisma produces its “magic from within”; “charisma produces a
transfiguration of identity” [5] (p. 67).
Charisma as an unpredictable, revolutionary force presents a disruptive capacity
for all established orders [3,5]. A charismatic situation creates a rupture with the usual
and institutionalized structures of behavior. A charismatic leader is not just a person
who inspires confidence, raises high expectations, or to whom special competencies are
ascribed. A charismatic leader establishes a new leadership position, a new structure of
social relationships, and a new cognitive definition of the action situation [4] (p. 5).
In this relationship between stigma and charisma, and despite considering stigma as a
mark or trait that devalues the individual [6], emphasizing the negative effects that it can
cause on individuals, stigma can be seen as the mark of something extraordinary that, on
the contrary, enhances the affirmation of the social status and symbolic power of the actors
characterized as ill-healthy (for example, COVID-19), in which labelling, stereotyping,
cognitive separation, and discrimination [7] tend to transform significantly, reinforcing the
admiration, trust, and belief in the chief by supporters and followers.
2. The COVID-19 Pandemic and the Stigmatization of the “Other”
The COVID-19 pandemic, like any other pandemic, is a health threat that can be
characterized by uncertainty, powerlessness, dystopia, and fear of the “other” [8]. The
belief in the association between contagion and danger intrinsic to the health threat caused
by COVID-19 has reinforced fears, prejudices, stigma, and xenophobia, reproducing a social
image of the dangerousness of the disease, the “impure” patients, the potential patients,
and the regions and countries associated with the genesis of the disease. The epidemic
is categorized as an attribute inherent in the invasion of the “strange”, the “foreign”, the
“other”.
COVID-19 shaped a stigma generally understood as full social disqualification, in
negative discrimination that generates exclusion [9–16].
The WHO (World Health Organization) [17] stated that three core factors underpin
the level of stigma arising from COVID-19: “[...] (1) it is a disease that’s new and for which
there are still many unknowns; (2) we are often afraid of the unknown; and (3) it is easy to
associate that fear with ‘others’. It is understandable that there is confusion, anxiety, and
fear among the public. Unfortunately, these factors are also fueling harmful stereotypes”
(p. 1).
Stigma corresponds to a mark or attribute that devalues the individual [6]. According
to Goffman [6], identity manipulation may occur in the relationship with others through
social information and full social acceptance—or not—based either on discredited attributes
(visible or known) or discreditable attributes (attributes that may become known). Stigma
is a mark or attribute that links the individual to undesirable characteristics, the stereotype.
Thus, stigma can affect individuals directly, through mechanisms of discrimination and
automatic activation of the stereotype, and indirectly, to the extent that it can threaten the
personal and social identity of the stigmatized individual [18].
COVID-19, as a contagious disease, seems obviously undesirable for everyone, so
its classification as a disease seems objective and self-evident. However, it is a social
assessment. Although this assessment focuses on the “disease”, it imposes on the “sick”
person to wish to be cured and seek technically competent help. Otherwise, the individual
would be freed from other roles and would not be responsible for their actions. The
nosological classification and social qualification of a given “disease” is not a socially
neutral process; medical management is characterized by the close articulation between
legitimacy and stigma. To consider someone as sick has immediate consequences for
their identity, and the medical qualification of a disease, even if it is a mistake, may be
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sufficient to introduce the individual into a career of sickness. Even if the illness has seen its
legitimacy recognized—having the right to be sick—the sick person cannot always avoid
stigmatization [19].
Stigmatization can be seen as a social process within a power relationship. Besides
emphasizing the interdependent relationships between “normal” and “stigmatized”, this
conceptualization allows this social phenomenon to be placed within a dynamic social, cul-
tural, economic, and political context. The process of stigmatization occurs when labelling,
stereotyping, cognitive separation, loss of status, and discrimination are interrelated in
a situation of power that allows such components to happen [7]. Power can be seen as
conducive to the process. Dominant groups have the ability to impose their values, norms,
and beliefs on people with fewer resources; stigmatization is a condition that promotes
inequality regarding the distributions of resources and power in a given society and time,
enabling the categorization and labelling of differences, the construction of stereotypes, the
separation between the “normal” and the “others”, disapproval, rejection, exclusion, and
discrimination [7].
This social process of stigmatization is characterized by several interdependent com-
ponents of categorization and labelling that negatively and continuously limit the life of
those who are victims of this process, such as labelling, stereotyping, physical and/or
social separation, status loss, discrimination, and exclusion by those considered in a given
social and cultural context normal or dominant in relation to others [6,7].
The mobilization of this conceptual perspective allows framing an analytical model
for understanding the social process of stigmatization associated with a disease in which
negative social representations emerge and are reinforced for certain groups of individu-
als [20,21]. This model has the following characteristics: the disease that is the object of
stigmatization is conceived as avoidable and considered to be under the control of those
affected; the behavior that caused the disease or the condition considered to be a risk of
a disease is the object of some form of disapproval, a moral judgement is performed on
people, and they are blamed for the disease or the behavior; the individuals or groups
affected by a given disease are associated with negative stereotypes (negative social repre-
sentations associated with the disease); people are associated with a socially differentiated
group, i.e., a labelled and stereotyped group with which a distancing is made based on
the existing social representations of the “other”; and people see their social status “dimin-
ished” and suffer various forms of disadvantage, whether the stigma is real, anticipated or
perceived [7,20,21].
3. COVID-19 and the Processes of Stigmatization
Every society has social control mechanisms to ensure that the majority of its members
conform to the socially dominant norms and rules. People who do not conform to these
rules or break social taboos are socially excluded [22]. For Becker and Arnold [22], members
of society have common beliefs about the cultural significance of an attribute and the stigma
attached to it. These beliefs about stigma dictate the nature of stigma. People take specific
attitudes about a given stigma and the responses of stigmatized people, thus affecting
the way in which a stigmatized individual is either integrated into a group or socially
excluded [22,23].
In the various representations conveyed in multiple discursive records about COVID-
19, this pandemic is associated with the matrix metaphor of the plague expressed in
the series contagion–death–medi-isolation. The contagion–epidemic dyad underlies the
perception of a great danger, amplified in contemporary societies by the extreme speed
of movement of people, goods, and information. The belief in the association between
contagion and danger intrinsic to epidemic diseases, namely the COVID-19 health threat,
has reinforced fears, prejudices, and enhanced stigma and xenophobia, reproducing a social
image of the dangerousness of the disease, the “impure” patients, the potential patients,
and the regions and countries associated with the genesis of the disease.
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Negative social representations associated with epidemics and contagions have per-
sisted over time, reinforcing prejudices and potentiating the stigmatization processes of
various groups of individuals and some regions. Hostile attitudes have been and continue
to be directed at groups categorized and socially labelled as having negative attributes in
relation to the dominant groups in certain contexts: the familia diaboli [24]—consisting of
beggars, vagabonds, Jews, “lepers”, prostitutes, gravediggers—in the plague epidemic in
the 14th century; the vagabonds and the destitute in the Renaissance in the epidemics of
black plague and typhus; Irish immigrants in the cholera epidemic in the 19th century;
the poor and working classes—the “dangerous classes”—in the outbreaks of tuberculosis
in the 19th and 20th centuries; homosexuals, Haitians, hemophiliacs, and heroin addicts
in the 1980s in the HIV/AIDS epidemic; the indigenous people of the European colonies
in the 19th century associated with the resurgence of leprosy; Africans linked with the
emergence of the “West Nile Virus”, the “Lassa Fever”, the “Ebola Virus”; and Chinese and
Asians in the H1N1, H5N1, SARS, and COVID-19 epidemics [25].
The stigma generated by COVID-19 is usually a source of shame, anxiety, and po-
tentially social rejection felt directly by the infected, stigmatized person (or the person
considered by others as a possible agent of infection) but also by those close to them
(family, friends, health professionals, and communities considered to be more conducive
to the existence and transmission of the virus, among others) [15,26–28]. Stigma is al-
most always regarded for its potentially negative characteristics of social rejection and
the various consequences involved, and the same has happened with its association with
COVID-19 [11,29–41], which may even reinforce pre-existing stereotypes, difficulties, and
negative images [33,42]. According to Joshi and Swarnakar [36] (p. 3), “All these cases of
infectious-disease stigma rely on a binary between the ‘normal’ and the ‘other’ in the form
of a culturally defined negative attribute or stigma to pass blame through social positions
of power and control”.
The stigma arising from COVID-19 has, therefore, an important effect on three di-
mensions of the infected individuals’ lives: (1) individual life and well-being: this stigma
reduces the individuals’ opportunities, negatively affects their ability to prevent and con-
trol health risks, causes the violation of human rights and dignity, increases physical and
psychological stress, and in many cases leads to self-stigma; (2) public health and pandemic
response: stigma hinders the detection and control of the disease, impacts health profes-
sionals, and contributes to increased mortality and morbidity; and (3) society at large: the
COVID-19 stigma causes increased social inequalities, notably through the marginaliza-
tion of those infected and the normalization of exclusion [43]. Table 1 shows how stigma
manifests in behaviors and its consequences on individuals.
Table 1. How stigma occurs and what impacts it has.
How Stigma Manifests Itself in Behaviors Consequences
- Blaming and shaming: questioning the etiology of the
pandemic, conspiracy theories, undesirable behaviors of a
specific group of individuals (e.g., eating live
bats/animals)
- Indifference, apathy, exclusion: deliberately accepting
unjust situations (e.g., isolating and excluding people who
have recovered from COVID-19, ignoring the death of
homeless people from COVID-19, or indifference to
COVID-19 infection within marginalized groups such as
prisoners, prostitutes, homosexuals, etc.)
- Preventing any connection and repudiation:
discrimination (e.g., refusing someone access to services,
use of the same space, or public transport)
Individual plan
Fear, feeling abandoned, angry, hurt
Despair, anxiety, depression
Isolation, withdrawal, alienation, suicide
Community/societal plan
Social segregation and punishment
Violence/crime against the victim
Dehumanization and violation of human rights
Protest, community resistance
Economic/political sanctions
Impact on control of COVID-19
Avoidance of contact tracing, hiding from surveillance
Avoiding/running away from medical care/treatment
Nonconformance to social measures
Putting people at greater risk through inability to access services
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Table 1. Cont.
How Stigma Manifests Itself in Behaviors Consequences
- Denying access: to employment, education, health
services, or housing (expulsion of the person from their
home or removal from schools)
- Verbal attacks, threats, harassment, pointing and
offending: ethnocentrism, prejudice, degrading
comments or looks, cursing, shouting
- Victimization and violence: physical assaults
The impact on health workers further weakens the health
system and the ability to control the pandemic
Source: WHO [44] (p. 6).
In summary, individuals infected with or considered to be infected with COVID-19 are
often seen as active agents of virus dissemination. This stereotypical view leads society to
treat these individuals negatively [15]. In the current pandemic situation, one aspect of the
salutogenic discourse focuses on the metaphor of body contamination, intensifying the sus-
ceptibility and aversion to body degradation. The sick, the old, the contaminated, and those
with bodily marks of physical decay tend to be excluded or ignored [45]. Nuckchady [34]
(p. 32) presents a categorization of infected individuals, and thus potential victims of
stigmatization, into the following four groups: “[...] stigma of people who are perceived to
be carriers of the disease but who most likely are not infected, stigma of people who are
actually infected, stigma of people who were infected but who have recovered and are no
longer contagious and stigma towards people who care for the ill”.
3.1. Stigma and Charismatic Domination
In almost all of the consulted studies that analyzed, directly or indirectly, the COVID-
19 pandemic and its social consequences, stigma and the process of stigmatization were
addressed in a socially negative way; i.e., the studies focused on the negative impacts
of stigma on the lives of people socially categorized as stigmatized [6,17,26,27,33,46,47].
Despite the negative effects that stigma can cause in individuals, stigma can be seen as
the mark of something extraordinary that, on the contrary, promotes the affirmation of the
social status and symbolic power of the actors characterized as ill-healthy, in which the
labelling, stereotyping, cognitive separation, and discrimination [7] tend to be significantly
transformed, reinforcing the admiration, trust, and belief in the charismatic leader by
supporters and followers. The indispensable presupposition is “to be believed”: the
charismatic leader has to be believed as a leader “by the grace of God” [3].
In the analysis of the configuration of the charismatic social relationship, the model
of charismatic domination proposed by Max Weber was favored. The Weberian model
offered the advantage of thematizing the issue of the relationship between the person and
the structure [4].
In this model, domination is viewed as a structure of power that not only demands
obedience, but demands obedience resulting from the will to obey [5]. Domination, as a
probability of finding obedience to a particular mandate, can be based on various motives
of submission [3]. The kinds of pretension that the holders of power have for the legitimacy
of their power shape the forms or types of domination: traditional, charismatic, and
rational–legal. Traditional domination is based on the appeal to the sanctity of habits and
immemorial traditions; rational–legal domination is based on formally approved rules and
statutes and has its archetype in the bureaucracy; and charismatic domination is based on
the personal gift of a heroic figure who is in a state of grace [3,5].
In charismatic domination, individuals obey the charismatically qualified chief be-
cause of personal trust in revelation, heroism, or exemplarity within the scope of the
validity of the belief in the chief’s charisma [3]. Leaders that exert this type of domination
are characterized by having a specifically extra quotidian character, presenting a strictly
personal social relationship associated with the charismatic validity of personal qualities
and their proof [3].
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Charisma, in the Weberian sense, is understood as a quality deemed extraordinary of
a person through which they are regarded as endowed with supernatural or superhuman
forces or characteristics not accessible to all, or else are seen as sent by God or as exemplary
and therefore as “chief ” [3] (pp. 706–707). Charisma is thus based on a social relationship
between a charismatic individual and a believer who is faithful to the charisma. The feature
considered charismatic is ascribed to an individual by their followers; in turn, the bearer of
charisma gains recognition of the charisma they claim. A social relationship is shaped in
which the position of the leader, the dominance exercised, and the form of obedience have
a specific nature [4]. Weber’s model is not oriented towards an analysis of the personality
of the charismatic leader, but towards the structure of the charismatic social relationship
characterized by a set of specific features [4].
The first feature concerns the recognition of the validity of the charisma by the dom-
inated, assured by the verification inherent in the revelation, the veneration of the hero,
the trust in the chief. The chief claims supreme authority, whereas the disciple accepts
obedience as a duty. The charismatic chief must be willing to claim supreme authority,
and the follower must be willing to submit entirely to the chief. The second feature of a
charismatic relationship regards the dissolution of previously existing norms, procedures,
and forms of organization. The more a charismatic chief makes claims about themselves
that they want all others to accept, the less they can allow for other normative rules and
control procedures. These would limit their arbitrariness by subjecting obedience to certain
conditions. The third feature is a consequence of the previous one. The social formation
that is shaped based on charismatic relationships is an “emotional communization”, the
cohesion of which is linked to a personal bond with the chief and that, when the size of the
group requires so, is organized by the disciples and trusted persons summoned by the chief.
The fourth feature of a charismatic relationship is the need for confirmation. The belief in
charisma, its ascription to a person, is dependent on the perception of confirmation. The ex-
pectations associated with the belief in charisma are not disconnected from the perception
of reality and the interests of those who believe in it. Confirmation can be attained when the
followers’ propensity to believe is reinforced by “enthusiasm, distress or hope” [4] (p. 4),
i.e., when the orientation of action is emotional and, when in a situation of uncertainty,
alternative interpretations and options for action are lacking. Once a charismatic leadership
position is established, its holder is likely to determine the perception of reality in their
followers and exclude alternative courses of action, deinstitutionalizing the processes of
intention and decision making [4] (p. 4).
The precondition for establishing charismatic dominance is the existence of a latent
charismatic situation, a propensity to believe in charisma and to submit to direct personal
dominance [4] (p. 5). This latent charismatic situation has two dimensions: one cultural
and one social [4]. The cultural dimension emphasizes that the propensity for charismatic
belief is culturally determined by the idea that transcendental powers directly influence
human destiny and are embodied in the qualities of an individual, who acts on behalf of a
God or “Providence”. In American culture, there is a relatively strong tendency towards
the belief in charismatic forces. The perception of a crisis underlies the social dimension of
a latent charismatic situation. The inability to overcome the crisis delegitimizes national
and international political institutions, which are held responsible for its genesis and
development; the hope grows that a “strong individual” will emerge to put an end to the
situation of distress. A latent charismatic situation emerges only when a charismatic claim
is made, when an individual seems to promise to overcome the crisis and this message is
deemed acceptable [4] (p. 7).
3.2. President Trump’s Legitimation Narrative of Charismatic Chieftaincy following a
SARS-CoV-2 Infection Reported by the Portuguese Media
The authors analyzed some selected news stories highlighted by several Portuguese
media about the actions and messages developed by President Trump in the context of his
SARS-CoV-2 infection and subsequent recovery process. These news items gave visibility
to a narrative that can be considered as reinforcing the legitimization of his condition as
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supreme leader in an electoral context marked by the pandemic threat. Different types of
public domain documentary sources were mobilized, namely newspapers, videos, posts,
and television reports (RTP, Portuguese Public Television), on the process of the infection
and recovery of President Trump.
It should be noted that public domain documents reflect two discursive practices:
as a genre of circulation, as artifacts of the sense of making public; and as content, in
terms of what is printed on their pages. They are “in time” products and significant
components of everyday life; they complement, supplement, and compete with narrative
and memory. Documents in the public domain, like records, are documents made public;
their intersubjectivity is a product of interaction with an unknown but meaningful and
often collective other [48].
Media can be understood as practices of meaning construction in public spaces, which
enable the configuration of shared universes and guide the topics of conversation of
social groups based on debates and polemics determined by the specific interests of these
groups [49]. The media are relevant in the process of the social construction of reality: they
guide the public’s attention and influence its perception of reality as well as determining
the social relevance of topics and what is under discussion in the social space.
In the news selected and reported by the Portuguese media on the infection and
recovery process of President Trump, the authors focused on identifying the thematic
structures of each text, which implied a reduction of the information to the central semantic
aspects. This reduction was performed through “macrorules”, namely the elimination of
redundant information and the summary of several propositions into a single, more generic
one, allowing the reconstruction of the texts in the form of “thematic skeletons” [50,51].
Macrostructures (organized sets of prepositions) as macropropositions were organized
into a set of categories emphasizing the causes of an event, the antecedents, and the conse-
quences [50,51], being relevant elements of a narrative that underlies the time sequence of
an action, an outcome, characters, and a framework of action [51].
The vicissitudes of President Trump’s recovery process were prolifically reported in
the media. In Portugal, multiple media considered to be of high quality and reliability
broadcast several reports on the recovery of President Trump in which the characteristics
of a charismatic leader can be highlighted (or, at least, the transmission of several of these
characteristics were present in some of the news reports) [52–54].
The Público newspaper, dated 2 October, 2020, reported that North American Presi-
dent Donald Trump was infected with the new coronavirus, along with first lady Melania
Trump:
“The information was advanced by the head of state himself via the social network Twitter.
‘Tonight, Melania and I tested positive for COVID-19. We will begin our quarantine
and recovery process immediately. We will get through this together,’ he wrote. Melania
Trump also confirmed on Twitter that the couple is infected. ‘As too many Americans
have done this year, Donald Trump and I are in quarantine at home after testing positive
for COVID-19. We are feeling fine and have postponed all engagements for the foreseeable
future. Please make sure you are safe and we will get through this together.’ The US
President’s physician, Sean Conley, has also confirmed this information and assured
that both ‘plan to stay at home inside the White House’ during their convalescence,
without saying, however, whether the couple has symptoms of the disease. ‘The White
House medical team and I will be keeping a watchful eye, and I appreciate the support
provided by some of the greatest medical professionals and institutions in our country.
Rest assured, I expect the President will continue to perform his duties uninterrupted
during his recovery, and I will keep you informed of any future developments,’ he stressed
in an official statement quoted by The New York Times. At 74 years of age, Trump falls
into one of the risk groups for COVID-19. According to the American daily, about eight
out of ten deaths attributed to the disease in the U.S. were recorded in citizens over
65 years. In May, and despite warnings from public health authorities, the President
had already stated that he was taking hydroxychloroquine (a drug used to treat malaria
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and autoimmune diseases such as rheumatoid arthritis or lupus) after two White House
staffers revealed that they were infected.
The isolation that Trump will now have to comply with will condition his campaign for the
November 3 presidential election, in which the Republican-backed candidate faces Demo-
crat Joe Biden, with whom he debated on Tuesday” (Pedro Guerreiro and Sofia Neves,
2 October 2020; https://www.publico.pt/2020/10/02/mundo/noticia/trump-
testa-positivo-covid19-entra-isolamento-plena-campanha-presidencial-1933713,
accessed on 17 October 2021)
A beneficial representation of the disease underlies these messages [55]. While in the
disease-bad-happiness model, individuals experience the disease as harmful, unbearable,
and responsible for the loss of their credibility, in the beneficial model, symptoms are not
considered as a deviation to be contained but as a message to be heard and decoded. Illness
is a reaction that has, if not a value, at least a meaning, since it is seen as an attempt to
restore the disturbed balance and even, in some cases, as an exalting and enriching episode.
The dominant beneficial representation of illness is that of the disease-salvation, in the
religious view, as a grace, holiness, that exalts, liberates, and enriches [55]. The disease is
felt as “liberating” when it offers the individual the possibility of escaping from a social
role perceived as suffocating and unbearable. Far from being perceived as a misfortune or
destruction, illness is seen as an opportunity to find meaning in one’s life, to affirm “new
life norms” that lead to the individual’s enrichment and fulfillment. This condition takes on
a negative or positive value depending only on how the individual lives it in relation to the
environment, i.e., in relation to the individual’s own normative power [56]. The experiences
and representations of a disease acquire meaning only through connection to the set of
interdependent relationships between individuals and society present in the interpretation
of the illness in a specific time and space. Thus, on the one hand, an illness expresses the
living conditions, values and belief systems, medical knowledge, and representations in a
given spacetime; on the other hand, an illness is “resented” by the individual only when
the signs that they perceive correspond to the symptoms that are socially recognized as
disease indicators [57–59].
President Donald Trump’s ritualized actions, as reported in some relevant Portuguese
media, embody something that goes beyond everyday normality in the sense of exalting
everyday behaviors. Rituals can be both routine and excessive, transporting the people
involved into a somewhat extraordinary world. These rituals can be understood as mani-
festos against indeterminacy [60,61], as symbolic acts that aim at mitigating uncertainties
and insecurities, fostering a feeling of ontological security among their adherents and fol-
lowers. Every rite tends to consecrate or legitimate, i.e., make an arbitrary limit recognized
as legitimate, as natural [62]. The “limit” that Bourdieu [62] mentions (p. 58) is the symbolic
line marking the passage between the before and the after. It is thus the line demarcated by
the rite that signals a change of state, the passage from one condition to another [62].
Rádio Televisão Portuguesa (RTP), a public television network, reported on 8 October,
2020, that President Trump, speaking of his early recovery at lines, said that contracting the
COVID-19 disease had been a “blessing from God” and that he wished all Americans had
“the same treatment as their President”:
“[...] US President Donald Trump said that contracting COVID-19 was a ‘blessing
from God’ and assured that it will help ‘heal’ other Americans, although he himself
has not yet overcome the disease. ‘It made me feel better, I call that healing. And I
want everyone to have the same treatment as their President’, Trump said in a video
posted on Twitter. [...] In this regard, Trump explained that his Administration plans
to approve, as a matter of urgency, the Regeneron cocktail he was administered and
assured that it will be distributed free of charge” (Mário Aleixo—RTP, 8 October
2020 (https://www.rtp.pt/noticias/mundo/covid-19-trump-diz-que-contrair-
a-doenca-foi-uma-bencao-de-deus_n1265044, accessed on 17 October 2021)
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The Expresso newspaper of 7 October reported that President Trump reiterated that
this was indeed a cure:
“They’re going to say that this is therapeutic, and maybe these medicines are really therapeu-
tic, some people don’t know how to define ‘therapeutic’, the views are different, but for me it’s
a cure. I went in, they gave me the treatment, and 24 h later I was perfect, I wanted to leave
the hospital. I want everyone to have the same treatment as your President. It was a blessing
from God. And I was the one who said I wanted to have this treatment. I want you to have the
same treatment and for free. You are not to blame for this, it’s China’s fault, China will pay”
(Expresso, 7 October 2020, https://expresso.pt/coronavirus/2020-10-07-Covid.
-Trump-diz-que-tratamento-que-recebeu-e-uma-cura-promete-oferece-lo-de-borla-
afirma-se-abencoado-por-Deus-e-ataca-a-China, accessed on 17 October 2021)
This narrative highlighted a set of actions and messages developed by President
Trump, which can be considered as reinforcing the legitimization of his charismatic leader
status in an electoral context marked by the pandemic threat.
These various news stories about President Trump’s infection with the new SARS
coronavirus COV-2 expressed the meanings that translate the semantic network of the
disease [63,64], the symbolic connections that a given individual establishes among their
various life experiences, particularly critical events and experiences. The meaning units
composed of words used to describe symptoms and sensations are connected by causal
relationships or by a metaphorical, analogical, or symbolic logic [64]. The logic inherent
in the semantic network allows one to go beyond the representations underlying the
etiological and therapeutic models, allowing the individual to interpret the disease within
their social and cultural context [64]. Language and representations have a symbolic
efficacy in constructing reality and structure the perception that social agents have of
society [65].
Following the media account exposed above, one possible interpretation is that, for
the American President and his supporters and followers, this miraculous nature of the
President’s healing expresses “the two bodies of the President”: human by its nature and
divine by the granting of God’s grace. The “presidential miracle” is presented as the ex-
pression of the supreme political power of the “Head of State”, who exercises a centralizing
power of physical and symbolic force. It is the affirmation of the symbolic dimension of
the President’s power. This President’s symbolic power is a power to consecrate or reveal
things that already exist. This symbolic power is founded on the possession of symbolic
capital, which is situated in the order of knowledge and recognition. The followers, the
dominated, know and recognize: the act of obedience presupposes an act of knowledge,
which, at the same time, is an act of recognition [65]. In the recognition, there is “knowl-
edge”; those who submit, obey, subject themselves to an order, operate a cognitive action.
The acts of submission and obedience are cognitive acts that operate cognitive structures,
categories of perception, schemes of perception, and principles of vision and division [65].
We recall that the leaders based on charismatic authority, when successful in a par-
ticular action or outcome, are perceived as having high competence, to the detriment of
their conventional peers who have not attained this success. Conventional leaders are
considered unworthy of leadership; they possess qualities that would have made them
worthy of leadership in the past but that, according to the new charismatic criteria, are a
sign of their unworthiness as leaders. That is, “[...] just as the charismatic leader impresses
the onlooker by means of a positive expression of their new vision and mission, so the
conventional contender performs the inadequacy of the status quo” [53] (p. 930).
The expression of the charismatic process, the new rules, the force, the proofs that
demonstrate the legitimacy of the charisma and the mission, are placed in a revolutionary
way in relation to the institutionalized situation through a social experience that demands
conversion (metanoia) in the followers’ attitudes and behavior, as in those of the leader
themselves. The reference to metanoia [66] shows that charisma touches an existential
sphere of experience and meaning of charismatic leaders [67]. Charisma can be interpreted
as a subjective “boundary experience”, because in this experience, individuals take on “a re-
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ligious worldview” without having to understand the process as a religious experience [68].
The experience of charisma can be seen as a religious experience, in the phenomenological
sense, even when the contents of the mission are manifested externally as secular, political,
or social action orientations [67,68].
4. Conclusions
As previously mentioned, this article aimed to analyze how stigma, as a social rela-
tionship, in the context of a pandemic threat such as COVID-19 can, in some situations,
structure the charismatic social relationship. Stigma, when considered as a mark of some-
thing extraordinary—a “grace from God”—that enhances the affirmation of the social
status and symbolic power of social actors characterized as ill-healthy, tends to signifi-
cantly transform the labeling, stereotyping, cognitive separation, and discrimination that
normally attend stigma, reinforcing the charismatic legitimacy of the leader and inspiring
the admiration, trust, and belief of their followers.
It was found that in the news selected and highlighted by several Portuguese media
about the actions and messages developed by President Trump as part of the recovery
process from an infection by SARS-CoV-2, a narrative was given visibility that can be
considered as reinforcing the legitimization of the President’s condition as the supreme
leader of the American nation. In this narrative, moral vocabularies [69] were produced
that could express to followers the belief in President Trump, who overcame the COVID-19
disease, and in his superiority and natural aptitude to lead, to govern; a fact potentially
reinforced by the President being perhaps so charismatic as to let the audience think a very
serious illness can be healed by the force of the Nation praying for the recovery of its own
President. Charismatic authority and legitimacy depend on the ability to simultaneously
convince followers that the leader has extraordinary powers and that the faith voluntarily
invested by followers in the chief does not fade [69]. The foundations of the “inspirational”
request for obedience are centered on the motto “obey me because I can transform your
life” [69] (p. 59).
In a charismatic social relationship, stigma, when viewed as the mark of something
extraordinary, may enhance the claims that individuals and dominant groups make about
themselves and that they want all others to accept [69]; it may reinforce the admiration,
trust, and belief in the charismatic leader by supporters and followers.
Stigmas can be considered symbolic maps revealing the political, social, and cultural
structures that give them meaning and sense, which are implicated in multiple regimes
of regulation [59]. A positive conception of stigma associated with illness can promote
the blurring of the moral boundaries that support the process of categorization and la-
beling of illnesses perceived as indecent, shameful, impure, polluting, and dirty [59].
Other challenges may arise, such as discussion on the implications of the positive and
negative components of stigma and the risk of stigmatization. Researchers and other
agents, namely politicians, must reflect on the challenges associated with a perspective
of “de-normalization” of stigma [59] and with stigmatization as a prevention and health-
promotion strategy [21,70].
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